Bullosis Diabeticorum

Bullosis Diabeticorum

Bullosis diabeticorum is a sudden blistering of the skin unique to patients with diabetes. It usually affects people between the ages of 17-84, and men are twice as likely as women to suffer from it. The cause of the disease is unknown. These lesions usually appear on the feet and toes, but occasionally on the hands and fingers. They are usually 0.5 to several centimetres in size, and contain a clear, sterile, viscous fluid.

There are two kinds of lesions. Intra-epidermal bullae are clear, sterile, non-haemorrhagic blisters that generally heal on their own within 2-5 weeks without scarring or atrophy. This type of bullae is more common in men with good circulation to the involved extremity (Bolognia and Braverman, 1998). Sub-epidermal bullae are the least common of the two types of bullosis diabeticorum (Huntley, 1982). These blisters are similar to the intra-epidermal blisters except they are occasionally subject to hemorrhage, and may heal with scarring and atrophy.

Bullosis diabeticorum is usually self-limiting; however, bacterial infections can result in deep infections (Huntley, 1982). Many, but not all, patients with this condition have nephropathy (any kidney disease) or neuropathy (any disease of the nervous system.) Bullosis diabeticorum tends to occur in patients with long-standing diabetes mellitus or with multiple complications of the disease. It has been reported to occur in approximately 0.5% of people with diabetes. Patients with uncomplicated or newly diagnosed diabetes also may be affected. Blisters may recur; lesions tend to heal without significant scarring. No significant morbidity is associated with this condition unless secondary infection occurs. One report has described inflammation of the bone and bone marrow arising at a site of bullosis diabeticorum. Local care to avoid blister eruption and appropriate antibiotic treatment for secondary infection is recommended.

Last Modified Date: November 28, 2012

All content on dLife.com is created and reviewed in compliance with our editorial policy.

Sign up for FREE dLife Newsletters

dLife Membership is FREE! Get exclusive access, free recipes, newsletters, savings, and much more! FPO

Congratulations!
You are subscribed!
Congratulations!
You are subscribed!
Congratulations!
You are subscribed!
96 Views 0 comments
by Chris Stocker
If you listen closely, you may hear the sound of 25 million Americans with diabetes rejoicing today. In a revolutionary movement, the FDA has given 510(k) approval on Abbott's HbA1C test which is expected to help millions of Americans with Type 1 or 2 diabetes or those at risk. Abbott's ARCHITECT Clinical Chemistry Hemoglobin A1C (HbA1C) test is a dramatic shift in diabetes diagnosis and monitoring. Instead of the HbA1C tests performed at a laboratory and constituted as blood work, the...